英文别名：
Mirtazapine;1,2,3,4,10,14B-HEXAHYDRO-2-METHYLPYRAZINO[2,1-A]PYRIDO[2,3-C][2]BENZAZEPINE;ORG-3770;MIRTAZANINE;MIRTAZEPINE;REMERON;1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c]benzazepine;1-a)pyrido(2,3-c)(2)benzazepine,1,2,3,4,10,14b-hexahydro-2-methyl-pyrazino(;2-Methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine;2-Methyl-1,2,3,4,10,14b-hexahydrobenzo-[c]pyrazino[1,2-a]pyrido[3,2-f]azepine;Mirtazapine solution;Mepirzepine;Remergil;Zispin;Remergon;Rexer;6-Azamianserin;Remeron SolTab;Mirtazapina;Mepirzapin;Mirtazipine;Promyrtil;Norset;Mirtazapinum;Avanza;ORG 3770;Mirtazapinum [INN-Latin];Mirtazapina [INN-Spanish];Mirtazapine [USAN:BAN:INN];Mirtazapine [USAN:INN:BAN];MIRTAZAPINE (EP MONOGRAPH);HMS3374J01;HMS3394H03;DB00370;Mirtazapin;Pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine, 1,2,3,4,10,14b-hexahydro-2-methyl-;FT-0672414;HMS3884O18;Mirtazapine (USAN:USP:INN:BAN);MLS006011449;NS00009441;D00563;Mirtazapine (Remeron, Avanza);HMS3677C11;HY-B0352;N06AX11;BRD-A64977602-001-01-9;MIRTAZAPINE (USP MONOGRAPH);SW197784-4;Mirtazapine- Bio-X;MIRTAZAPINE (USP-RS);MIRTAZAPINE [VANDF];BCP14560;2-methyl-1,2,3,4,9,13b-hexahydro-2,4a,5-triaza-tribenzo[a,c,e]cycloheptene;PDSP1_001529;Smilon;PS11 - Mirtazapine/Normirtazapine;5-methyl-2,5,19-triazatetracyclo[13.4.0.0?,?.0?,??]nonadeca-1(15),8,10,12,16,18-hexaene;Org3770;Mirataz;Mepirzapine;Mirtazapine (JAN/USP/INN);C07570;5-methyl-2,5,19-triazatetracyclo[13.4.0.0^{2,7}.0^{8,13}]nonadeca-1(19),8,10,12,15,17-hexaene;Reflex (TN);2-methyl-1,2,3,4,10,14b-hexahydropyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine;HMS2052H03;MIRTAZAPINE [USAN];85650-52-8;SCHEMBL35408;HMS3268F21;HMS3657M13;CCG-220556;(14bR)-2-methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine;AC-15480;Mirtazapine anhydrous;ME-2040;AB00698265_08;NCGC00025346-08;SR-01000597530;PDSP2_001513;Mirtazapine, 1mg/ml in Methanol;Mianserin, 6-Aza-;s2016;Mirtazapina (INN-Spanish);HMS3413C11;1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c](2)benzazepine;BRD-A64977602-001-04-3;Mirtazapine, European Pharmacopoeia (EP) Reference Standard;Mirtazapine 1.0 mg/ml in Methanol;L001294;Azamianserin;MIRTAZAPINE [MI];CHEBI:6950;2-methyl-1,2,3,4,10,14b-hexahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepine;MLS000759460;HMS2233K03;HMS3713P13;UNII-A051Q2099Q;MLS001424294;Remeronsoltab;DTXSID0023325;MIRTAZAPINE [USP MONOGRAPH];MIRTAZAPINE [WHO-DD];Q421930;MFCD00865427;1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine;BCP22244;Z905065772;NCGC00025346-02;MIRTAZAPINE [ORANGE BOOK];SR-01000597530-1;DTXCID503325;(S)-Org3770;(S)-6-Azamianserin;FT-0628951;A914630;(1)-1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine;MIRTAZAPINE, (+/-)-;SMR000466347;Tox21_110965;Remeron (TN);Pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine, 1,2,3,4,10,14b-hexahydro-2-methyl-, (.+/-.)-;BCP9000930;MIRTAZAPINE [USP-RS];Mirtazapine [USAN:USP:INN:BAN];GTPL7241;61337-67-5;CCG-101154;MIRTAZAPINE [GREEN BOOK];EINECS 288-060-6;Mirtazapine, >=98% (HPLC);HMS3370B05;6 Azamianserin;5-methyl-2,5,19-triazatetracyclo[13.4.0.0^{2,7}.0^{8,13}]nonadeca-1(19),8(13),9,11,15,17-hexaene;Mirtazapine for system suitability, European Pharmacopoeia (EP) Reference Standard;CHEMBL654;SR-01000597530-4;A051Q2099Q;EN300-49851;(14bRS)-1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine;NC00404;CAS-61337-67-5;MLS001076676;BM164672;NCGC00025346-01;(+/-)-12-Methyl-1,2,3,4,9,13b-hexahydro-2,4a,5-triaza-tribenzo[a,c,e]cycloheptene;FT-0601544;AKOS005530681;Mirtazapinum (INN-Latin);5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene;BDBM50115644;MIRTAZAPINE [JAN];KS-1086;M2151;Pyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine, 1,2,3,4,10,14b-hexahydro-2-methyl-;MIRTAZAPINE [INN];Mirtazapine, United States Pharmacopeia (USP) Reference Standard;MIRTAZAPINE [EP MONOGRAPH];(R)-Org3770;(R)-6-Azamianserin;BRD-A64977602-001-13-4;BRD-A64977602-001-15-9;STK711107;BRD-A64977602-001-14-2;
1148980033 
